CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge.
about
Phosphodiester CpG oligonucleotides as adjuvants: polyguanosine runs enhance cellular uptake and improve immunostimulative activity of phosphodiester CpG oligonucleotides in vitro and in vivoProphylactic application of CpG oligonucleotides augments the early host response and confers protection in acute melioidosisBroad-Spectrum Drugs Against Viral AgentsAdjuvant effects of CpG oligodeoxynucleotides on responses against T-independent type 2 antigensEffective, broad spectrum control of virulent bacterial infections using cationic DNA liposome complexes combined with bacterial antigensCpG-oligodeoxynucleotide is a potent adjuvant with an Entamoeba histolytica Gal-inhibitable lectin vaccine against amoebic liver abscess in gerbilsShort- and long-term changes in gene expression mediated by the activation of TLR9Formulation with CpG oligodeoxynucleotides prevents induction of pulmonary immunopathology following priming with formalin-inactivated or commercial killed bovine respiratory syncytial virus vaccinePrevention and treatment of cutaneous leishmaniasis in primates by using synthetic type D/A oligodeoxynucleotides expressing CpG motifs.Repeated administration of synthetic oligodeoxynucleotides expressing CpG motifs provides long-term protection against bacterial infection.Interleukin-12- and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice.Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.Enhancement of innate immunity against Mycobacterium avium infection by immunostimulatory DNA is mediated by indoleamine 2,3-dioxygenase.CpG oligodeoxynucleotides increase the susceptibility of normal mice to infection by Candida albicans.DNA containing CpG motifs induces angiogenesis.CpG oligodeoxynucleotides enhance host defense during murine tuberculosisImproved immunogenicity and efficacy of the recombinant 19-kilodalton merozoite surface protein 1 by the addition of oligodeoxynucleotide and aluminum hydroxide gel in a murine malaria vaccine model.CpG oligodeoxynucleotides improve the survival of pregnant and fetal mice following Listeria monocytogenes infection.Prevention and therapy of hepatocellular carcinoma by vaccination with TM4SF5 epitope-CpG-DNA-liposome complex without carriersSystemic treatment with CpG-B after sublethal rickettsial infection induces mouse death through indoleamine 2,3-dioxygenase (IDO).Induction of CD8 T-cell-specific systemic and mucosal immunity against herpes simplex virus with CpG-peptide complexes.CpG oligodeoxynucleotides stimulate protective innate immunity against pulmonary Klebsiella infectionA protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection.A CpG oligonucleotide can protect mice from a low aerosol challenge dose of Burkholderia mallei.Mucosal immunization with helicobacter, CpG DNA, and cholera toxin is protective.Toll-like receptor 9: a new target of ischemic preconditioning in the brain.Orally administered CpG oligodeoxynucleotide induces production of CXC and CC chemokines in the gastric mucosa and suppresses bacterial colonization in a mouse model of Helicobacter pylori infectionToll-like receptor 3 is a potent negative regulator of axonal growth in mammals.Combining vaccination and postexposure CpG therapy provides optimal protection against lethal sepsis in a biodefense model of human melioidosis.Oral pretreatment of mice with CpG DNA reduces susceptibility to oral or intraperitoneal challenge with virulent Listeria monocytogenes.Cytotoxic-T-lymphocyte human papillomavirus type 16 E5 peptide with CpG-oligodeoxynucleotide can eliminate tumor growth in C57BL/6 mice.CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells.Design and Structural Requirements of the Potent and Safe TLR-9 Agonistic Immunomodulator MGN1703.CpG oligodeoxynucleotide treatment enhances innate resistance and acquired immunity to African trypanosomes.Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouse.CpG-induced IFNgamma expands TLR4-specific IL-18 responses in vivo.Molecular chaperoning by glucose-regulated protein 170 in the extracellular milieu promotes macrophage-mediated pathogen sensing and innate immunity.Cationic liposomes extend the immunostimulatory effect of CpG oligodeoxynucleotide against Burkholderia pseudomallei infection in BALB/c mice.A combination hydrogel microparticle-based vaccine prevents type 1 diabetes in non-obese diabetic mice.Activation of type I interferon-dependent genes characterizes the "core response" induced by CpG DNA.
P2860
Q24682799-BEC91B58-F51B-48AD-BF16-96E40A7D95B6Q27305350-C605424F-43F0-4E47-A834-2BFA97A3E549Q27487859-708AB775-7A1F-4223-9AF0-8AB01B4385C6Q28347424-AFA36BCA-4128-4651-9EC0-278B0A6FFC1DQ28474115-E4E3948F-332D-488F-BEEC-18A32FCE236CQ30446957-74D86601-E193-44D7-8CBB-8C33AEBD5311Q33695664-8F4F9114-2426-4B5D-AE08-F6E606DB8CF6Q33781642-6BA98894-5000-4D38-9C4E-0969B53E34B0Q33946716-5711AD35-80DD-4283-88F6-7E1C9C4B727EQ34002329-2662027D-E3B4-4B64-B41C-A23564BC53C4Q34006411-00B24E48-1236-4642-80DA-9551F044EF35Q34008507-FFB9A23A-1246-4CF6-A6BF-9D26EE847CD6Q34009281-0BF8223F-4A2C-4DD0-A9DB-D3C9EEC1E922Q34034008-C0B07E6B-625A-447F-9E05-9B41F26299A0Q34066361-C3EE1950-1081-48C7-8F44-585A09152D0DQ34115834-8A9A99D5-8DA4-4DDA-9DAB-CCB7E3B6B0A0Q34118325-B6B5F4EC-B590-4803-88F1-4D81C943384EQ34145320-377E4478-0532-4DB2-B5C9-969FB75BF68AQ34200500-B41CAFD6-4129-46EF-9E3F-02E276B4D95CQ34217664-19D8F228-3376-4E5A-94FA-12590523F615Q34340988-6B5C9515-AB74-4E09-8C65-B602D18B64ADQ34402230-DC0E898C-685F-4EFE-92AE-25EA8EF66D7DQ34465399-538A6CAB-CF3A-461E-89BE-42FE88E6DC92Q34491754-54851EF8-D588-43FD-B376-9F746CD54F9BQ34522227-0B87BCA7-8CB3-4422-908B-4AC613B229BBQ34566966-F4D2F92F-3842-4B07-8E59-F515C412A406Q34941937-0DE5A096-84BB-41C9-BA32-0023A792C0F2Q35037100-BCD89217-B360-4ACB-B47E-3A1C3B9E6158Q35129390-A3AD7FCE-CCC6-4A0C-8E14-7099FC1C4B5FQ35165446-273820EB-0E41-4AC7-86B1-9DA3CA182F1FQ35543857-73A525A6-119A-4617-BA99-042B583D1829Q35602700-62D691F9-55B9-4126-8819-85294B4AC40CQ35635250-A365D9C0-792A-4725-9624-0F6957FFBE2CQ35784051-66010122-6C23-4D49-8CD1-3EEA57C0F599Q35828638-F04D9320-685A-46F3-91CD-A718D584055AQ35842807-3E090B0C-24C2-480F-8826-00A77A201E48Q35863823-B282728B-5A59-40D0-9823-877B75B05EF3Q35940681-FA77072E-F133-4754-982B-A3C621A6F4A1Q35960520-E3E806DC-AA3D-402E-956F-8592A04D438FQ36232223-4AAD19B0-070B-4F6C-B396-034EA36AF3EA
P2860
CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge.
description
1998 nî lūn-bûn
@nan
1998 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
name
CpG DNA induces sustained IL-1 ...... teria monocytogenes challenge.
@en
CpG DNA induces sustained IL-1 ...... teria monocytogenes challenge.
@nl
type
label
CpG DNA induces sustained IL-1 ...... teria monocytogenes challenge.
@en
CpG DNA induces sustained IL-1 ...... teria monocytogenes challenge.
@nl
prefLabel
CpG DNA induces sustained IL-1 ...... teria monocytogenes challenge.
@en
CpG DNA induces sustained IL-1 ...... teria monocytogenes challenge.
@nl
P2093
P1476
CpG DNA induces sustained IL-1 ...... teria monocytogenes challenge.
@en
P2093
P304
P407
P577
1998-09-01T00:00:00Z